DXCM vs STE — Key Metrics

Metric DXCM (DEXCOM INC) STE (STERIS PLC)
Price82.52259.57
Market Cap30.78 Billion25.21 Billion
P/E (TTM)31.8630.68
P/B (Quarterly)11.7583.4
P/S (TTM)6.034.09
Net Profit Margin (TTM)19.413.4
Gross Margin (TTM)63.444.6
ROE (TTM)36.511.5
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

DEXCOM INC
vs
 
STERIS PLC
 
DEXCOM INC
vs
 
STERIS PLC
Performance Comparison
AI Model Recommendation
DXCM · DEXCOM INC

Outperform

13
UnderperformOutperform
STE · STERIS PLC

Greatly Underperform

-92
UnderperformOutperform
Recommendation Summary

Stock DXCM is projected to outperform the market, stock STE is projected to greatly underperform the market. Upfront Recommendation: DXCM.

Financial Metrics
Prices delayed ~15 min
DXCM Metrics STE
$82.52 Price $259.57
— Market Capitalization —
31.86 Price to Earnings Ratio 30.68
6.03 Price to Sales 4.09
28.02 Price to FCF Ratio 26.6
9.51 Price to Gross Profit 9.17
50.61 Price to R&D 212.89
7.86 Price to Current Assets 10.17

DXCM vs STE at a glance

Dexcom INC (DXCM) and Steris PLC (STE) are both Medical Devices companies in the Healthcare sector. DXCM is the larger, at $30.8 billion in market value against $25.2 billion for STE, about 1.2 times the size.

On trailing-twelve-month figures, DXCM trades at 31.9 times trailing earnings and STE at 30.7; net profit margins are 19.4% and 13.4%.

The Upfront Investment model currently rates DXCM Outperform and STE Greatly Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.